Search filters

List of works by Maryalice Stetler-Stevenson

2006 Bethesda International Consensus Conference on Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasia

scientific article published in January 2007

5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox

scientific article published on 5 February 2018

A QA program for MRD testing demonstrates that systematic education can reduce discordance among experienced interpreters

scientific article published on 5 May 2017

A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma

scientific article published on 21 March 2014

Abstract 4356: Cytotoxicity of the anti-CD22 immunotoxin HA22 against pediatric acute lymphoblastic leukemia (ALL)

Abstract CT230: Pediatric phase 1 trial of moxetumomab pasudotox: Activity in chemotherapy refractory acute lymphoblastic leukemia (ALL)

Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia

scientific article published on 13 August 2018

Albumin enhanced morphometric image analysis in CLL.

scientific article published on January 2004

Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial

scientific article

Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia ⬇️

scientific article published on December 14, 2012

Assessment of Discordance Among Smoldering Multiple Myeloma Risk Models

scientific article published on 19 November 2020

Assessment of minimal residual disease in myeloma and the need for a consensus approach

scientific article published on 22 July 2015

B-cell repertoire and clonal analysis in unaffected first degree relatives in familial chronic lymphocytic leukaemia kindred

scientific article published on 17 October 2007

Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma

article

Bendamustine and rituximab in relapsed and refractory hairy cell leukemia

scientific article

Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation

scientific article

Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation

scientific article

CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial

scientific article published on 14 April 2020

Case study interpretation--Portland: Case 1. Hairy cell leukemia with CLL-like monoclonal B lymphocytosis

scientific article published on 19 March 2012

Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders

scientific article published on 01 October 2011

Characterization of CD22 expression in acute lymphoblastic leukemia

scientific article published on March 2015

Characterization of T-cell repertoire in hairy cell leukemia patients before and after recombinant immunotoxin BL22 therapy

scientific article published on 26 November 2005

Chronic active Epstein-Barr virus infection: a novel cause of lymphocytic variant hypereosinophilic syndrome

scientific article published in March 2013

Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia

scientific article

Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib

scientific article published on 20 March 2020

Clinical quantitative flow cytometry: "Identifying the optimal methods for clinical quantitative flow cytometry".

scientific article published in September 2003

Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia

scientific article published on 3 January 2017

Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma

scientific article published on 04 May 2018

Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity

scientific article published on 8 September 2015

Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition

scientific article

Contributors

Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation

scientific article published on 30 January 2012

Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia

scientific article published on 07 June 2010

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase II study

scientific article published on 26 February 2018

Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.

scientific article

Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious

scientific article published on 01 June 2006

Diagnosis of hairy cell leukemia by flow cytometry ⬇️

scientific article published on April 19, 2011

EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies

scientific article published on 17 March 2009

Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other KSHV-associated disorders

scientific article published on 17 September 2020

Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis

scientific article published on 01 August 2019

Enzymatic activities of circulating plasma proteasomes in newly diagnosed multiple myeloma patients treated with carfilzomib, lenalidomide and dexamethasone.

scientific article

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 ⬇️

scientific article published on July 28, 2010

Evidence of canonical somatic hypermutation in hairy cell leukemia ⬇️

scientific article published on March 2, 2011

Expression of the IL-6 receptor alpha-chain (CD126) in normal and abnormal plasma cells in monoclonal gammopathy of undetermined significance and smoldering myeloma

scientific article published on 25 May 2017

Expression of the muscle-associated gene MYF6 in hairy cell leukemia

scientific article published on 10 February 2020

FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins

scientific article

Flow Cytometric Immunophenotypic Assessment of T-Cell Clonality by Vβ Repertoire Analysis in Fine-Needle Aspirates and Cerebrospinal Fluid ⬇️

scientific article published on 01 February 2012

Flow Cytometric Monitoring for Residual Disease in B Lymphoblastic Leukemia Post T Cell Engaging Targeted Therapies

scientific article published on 13 September 2018

Flow Cytometry Immunophenotyping of Hematolymphoid Neoplasia ⬇️

scientific article published on 01 January 2011

Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases

scientific article published on 11 December 2013

Flow cytometric immunophenotypic assessment of T-cell clonality by Vβ repertoire analysis: detection of T-cell clonality at diagnosis and monitoring of minimal residual disease following therapy

scientific article published in June 2011

Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow

scientific article

Flow cytometric immunophenotyping of cerebrospinal fluid

scientific article published on 01 July 2008

Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method

scientific article published on 30 October 2014

Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium

scholarly article by Ola Landgren et al published 19 November 2014 in American Journal of Hematology

Flow cytometry increases the sensitivity of detection of leukemia and lymphoma cells in bronchoalveolar lavage specimens ⬇️

scientific article published on July 26, 2012

High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology

scientific article published on 9 September 2004

ICCS Women in Cytometry-Impact 10 years later: A call to promote gender equity

scientific article published on 24 August 2020

Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial

scientific article

Immunoglobulin light chain repertoire in hairy cell leukemia

scientific article published on 25 April 2007

Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia

scientific article published on July 2008

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

scientific article published on 10 May 2017

Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma ⬇️

scientific article published on December 2, 2013

Minimal residual disease detection by flow cytometry in adult T-cell leukemia/lymphoma

scientific article published on 01 April 2010

Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene

scientific article published on 01 February 2003

Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction

scientific article published on 01 May 2006

Minimal residual disease in multiple myeloma: bringing the bench to the bedside

scientific article

Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity ⬇️

scientific article published on August 8, 2013

Minimal residual disease: what are the minimum requirements?

scientific article published on 13 January 2014

Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase I results and long-term follow-up

scientific article published on 27 February 2018

Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study ⬇️

scientific article published on July 29, 2013

Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications ⬇️

scientific article published on April 20, 2011

Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: Diagnostic and therapeutic challenges ⬇️

scientific article published on April 4, 2012

Myeloma minimal residual disease testing in the United States: Evidence of improved standardization

scientific article

Novel CD19 expression in a peripheral T cell lymphoma: A flow cytometry case report with morphologic correlation

scientific article

PRAME expression in hairy cell leukemia

scientific article published on 4 March 2008

Paradoxical central nervous system immune reconstitution syndrome in acquired immunodeficiency syndrome-related primary central nervous system lymphoma

scientific article published on 10 October 2014

Pathological findings in human autoimmune lymphoproliferative syndrome

scientific article published on November 1998

Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.

scientific article published on 15 October 2009

Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia

scientific article

Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy

scientific article

Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia.

scientific article published on 12 July 2011

Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia

scientific article

Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies

scientific article published on 01 August 2005

Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies

scientific article published on April 2000

Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphoma

scientific article

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma

scientific article

Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia

scientific article published on 04 May 2009

Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22

scientific article published on 06 November 2018

Quantification of expression of antigens targeted by antibody-based therapy in chronic lymphocytic leukemia

scientific article

Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia

scientific article published on 28 February 2020

Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia ⬇️

scientific article published on May 18, 2013

Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia ⬇️

scientific article published on June 1, 2011

Response of hairy cell leukemia to bendamustine ⬇️

scientific article published on 04 April 2011

Role of Flow Cytometry of Peripheral Blood and Bone Marrow Aspirates in Early Myeloma ⬇️

scientific article published on January 1, 2011

Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma

scientific article

Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma

scientific article published in February 2018

Soluble CD22 as a tumor marker for hairy cell leukemia

scientific article published on 2 July 2008

T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma

scientific article published on 13 July 2016

The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia ⬇️

scientific article published on October 12, 2010

Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors

scientific article

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

scientific article

Tumour-derived GM-CSF promotes granulocyte immunosuppression in mesothelioma patients.

scientific article published on 30 March 2018

Usefulness of Dual Immunohistochemistry Staining in Detection of Hairy Cell Leukemia in Bone Marrow

scientific article published on 01 February 2020

VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy

scientific article

Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma

scientific article published on 21 August 2005

Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy

scientific article

Variables affecting the quantitation of CD22 in neoplastic B cells ⬇️

scientific article published on September 24, 2010

Variables in the quantification of CD4 in normals and hairy cell leukemia patients ⬇️

scientific article published on January 1, 2011

Visual inspection versus quantitative flow cytometry to detect aberrant CD2 expression in malignant T cells

scientific article

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

scientific article published on 20 February 2003

Paulina is supported by:

About Paulina

Help